Skip to main content
Back
Watch Compare

SERA PROGNOSTICS, INC.

Data quality: 100%
SERA
NASDAQ Services Health Services
$1.97
▼ $0.12 (-5.74%)
Mkt Cap: 84.16 M
Price
$2.15
Mkt Cap
84.16 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -0.31% annually over 5 years
Negative free cash flow of -26.35 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.50%
Capital intensive — 896.30% of revenue goes to capex

Growth

Revenue Growth (5Y)
-0.31%
Below sector avg (3.76%)
Revenue (1Y)5.19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-37.47%
Below sector avg (-15.99%)
ROIC-33.37%
Net Margin-39417.28%
Op. Margin-45066.67%

Safety

Debt / Equity
N/A
Current Ratio1.89
Interest Coverage-4056.00

Valuation

PE (TTM|NTM)
-2.64 | -2.94
Below sector avg (-1.17)
P/B Ratio1.02
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (515 peers)
Metric Stock Sector Median
P/E -2.6 -1.2
P/B 1.0 1.4
ROE % -37.5 -16.0
Net Margin % -39417.3 -19.4
Rev Growth 5Y % -0.3 3.8
D/E — 0.4

Analyst Price Target

1 analyst
Buy
Current
$1.97
+153.8%
Target
$5.00
$5.00
$5.00
$5.00
Forecast
Forward P/E -2.94
Forward EPS -$0.67
Est. Revenue 2.17 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.67
-$0.68 – -$0.66
 2.17 M 2
FY2026 -$0.68
-$0.73 – -$0.63
 348,000.0 2

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.19 -$0.16 +15.8%
Q32025 -$0.21 -$0.16 +23.8%
Q22025 -$0.24 -$0.16 +33.3%
Q12025 -$0.21 -$0.20 +4.8%

ETFs Holding This Stock

BRSIX BRSIX
0.32% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 5.19% Revenue Growth (3Y) -48.55%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -0.31% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 81,000.0 Net Income (TTM) -31.93 M
ROE -37.47% ROA -29.03%
Gross Margin N/A Operating Margin -45066.67%
Net Margin -39417.28% Free Cash Flow (TTM) -26.35 M
ROIC -33.37% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.89
Interest Coverage -4056.00 Asset Turnover 0.00
Working Capital 20.99 M Tangible Book Value 81.24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.64 Forward P/E -2.94
P/B Ratio 1.02 P/S Ratio 1039.00
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 38.72 Fwd Earnings Yield N/A
FCF Yield -31.31%
Market Cap 84.16 M Enterprise Value 80.08 M
Per Share
EPS (Diluted TTM) -0.67 Revenue / Share 0.00
FCF / Share -0.67 OCF / Share -0.65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 896.30% FCF Conversion 82.53%
SBC-Adj. FCF -32.12 M Growth Momentum 5.50

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 81,000.0 77,000.0 306,000.0 268,000.0 82,000.0
Net Income -31.93 M -32.90 M -36.24 M -44.19 M -35.01 M
EPS (Diluted) -0.67 -0.99 -1.16 -1.43 -2.33
Gross Profit — — — — —
Operating Income -36.50 M -36.64 M -39.82 M -45.65 M -35.40 M
EBITDA — — — — —
R&D Expenses 13.17 M 14.73 M 15.23 M 14.24 M 11.02 M
SG&A Expenses — — — — —
D&A 940,000.0 833,000.0 900,000.0 756,000.0 659,000.0
Interest Expense 9,000.0 28,000.0 — — —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 101.93 M 72.58 M 95.44 M 116.33 M 147.03 M
Total Liabilities 26.53 M 24.77 M 25.28 M 17.39 M 8.47 M
Shareholders' Equity 75.41 M 47.80 M 70.16 M 98.94 M 138.56 M
Total Debt — — — — —
Cash & Equivalents 3.94 M 4.04 M 3.88 M 29.88 M 58.93 M
Current Assets 40.77 M 47.60 M 61.34 M 90.13 M 110.25 M
Current Liabilities 24.19 M 24.77 M 24.44 M 15.54 M 8.41 M